Conivaptan is approved by the United States Food and Drug Administration (FDA) for hypervolemic (nephrotic syndrome, cardiac failure and cirrhosis) or euvolemic
hyponatremia (SIADH) treatment in adults, but not in children (10).
Dose comparison of conivaptan (Vaprisol[R]) in patients with euvolemic
or hypervolemic hyponatremia-efficacy, safety, and pharmacokinetics.
: Those patients who had no signs mentioned above were considered to be euvolemic
In a 2010 study of ICU patients, urea was used to treat euvolemic
hyponatremia and was found a safe, inexpensive, and simple.
The question arises whether it is possible to infuse fluids to a continuously euvolemic
Effects of saline infusion on hematologic parameters in euvolemic
Based on history and clinical examination patients were classified as hypovolemic hyponatremia, hypervolemic hyponatremia and euvolemic
Of the 25 patients at baseline, 21 were clinically euvolemic
. Twelve of 15 patients who had a follow-up ASFM and SGA were clinically euvolemic
Both are indicated for euvolemic
and hypervolemic HN.
Cardiology evaluated the patient and recommended medical optimization and diuresis with plans for eventual right and left heart catheterization once he was euvolemic
. Gastroenterology evaluated the patient for his abdominal pain, nausea, vomiting, and elevated LFTs.
Clinical examination indicated euvolemic